Walleye Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.3M | Buy |
11,057
+3,031
| +38% | +$1.18M | 0.02% | 427 |
|
|
2025
Q1 | $3.49M | Sell |
8,026
-3,726
| -32% | -$1.62M | 0.02% | 450 |
|
|
2024
Q4 | $4.34M | Buy |
11,752
+7,482
| +175% | +$2.76M | 0.01% | 476 |
|
|
2024
Q3 | $2.22M | Buy |
4,270
+4,060
| +1,933% | +$2.11M | ﹤0.01% | 720 |
|
|
2024
Q2 | $114K | Sell |
210
-4,962
| -96% | -$2.69M | ﹤0.01% | 2026 |
|
|
2024
Q1 | $2.68M | Sell |
5,172
-23,033
| -82% | -$11.9M | ﹤0.01% | 666 |
|
|
2023
Q4 | $13.3M | Buy |
28,205
+19,970
| +243% | +$9.42M | 0.03% | 148 |
|
|
2023
Q3 | $3.59M | Buy |
8,235
+3,675
| +81% | +$1.6M | 0.01% | 470 |
|
|
2023
Q2 | $2.03M | Buy |
4,560
+3,722
| +444% | +$1.65M | 0.01% | 512 |
|
|
2023
Q1 | $385K | Buy |
+838
| New | +$385K | 0.01% | 1086 |
|
|
2020
Q1 | – | Sell |
-822
| Closed | -$248K | – | 648 |
|
|
2019
Q4 | $248K | Sell |
822
-424
| -34% | -$128K | 0.02% | 314 |
|
|
2019
Q3 | $299K | Buy |
+1,246
| New | +$299K | 0.02% | 122 |
|
|
2019
Q2 | – | Sell |
-825
| Closed | -$237K | – | 615 |
|
|
2019
Q1 | $237K | Buy |
+825
| New | +$237K | 0.04% | 59 |
|
|
2018
Q3 | $560K | Buy |
+2,044
| New | +$560K | 0.26% | 104 |
|